What we are studying
People with type 2 diabetes have a higher risk of getting cardiovascular disease (disease of the heart and/or blood vessels) than people without diabetes. Cardiovascular disease may cause serious complications such as heart attack or stroke. Albiglutide is a medicine (given as a weekly injection) used to lower blood sugar levels in people with diabetes. The purpose of this study is to find out whether people taking albiglutide for diabetes have a higher or lower risk of developing cardiovascular complications (heart attack, stroke, or death from cardiovascular disease), than people who do not take albiglutide. The study will also look for the possibility of additional benefits of albiglutide on the management of your diabetes. For example, whether abliglutide can delay the time you might need to start on insulin treatment, and whether albiglutide can improve your diabetes control without causing side effects such as weight gain or low blood sugar levels (hypoglycemia). The study will also collect important safety information to help improve understanding about the overall effects of albiglutide (both good and bad).
Compensation for participation is available